Record Information
Version1.0
Creation Date2019-07-14 16:37:22 UTC
Last Updated2019-10-01 21:41:38 UTC
CypComp IDCC02199
Compound Information
NameTolterodine
Structure ImageOogjqpclvadcpb hxuwfjfhsa n
InChIKeyOOGJQPCLVADCPB-HXUWFJFHSA-N
PubChem ID443879
CypCompound Information
SetCypBoM Training Set
Bonds of Metabolism (BoMs)
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
  • Not Available
  • Not Available
  • Not Available
  • Not Available
  • <19,18;Cleavage;R1>
  • <19,H;Oxidation;R1>
  • <20,18;Cleavage;R2>
  • <20,H;Oxidation;R2>
  • <19,18;Cleavage;R1>
  • <19,H;Oxidation;R1>
  • <20,18;Cleavage;R2>
  • <20,H;Oxidation;R2>
  • <9,H;Hydroxylation;R1>
  • Not Available
  • <19,18;Cleavage;R1>
  • <19,H;Oxidation;R1>
  • <20,18;Cleavage;R2>
  • <20,H;Oxidation;R2>
References
  1. Postlind H, DanielsonA, Lindgren A, Andersson SH: Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Drug Metab Dispos. 1998 Apr;26(4):289-93. [PubMed:9531513 ]
Download FileCC02199.sdf